mikejuk writes "Google's Dart just reached version 1.0, but now it seems that it has aspirations to being an international standard. The question is will this make any difference to the language's future? Given that Google effectively owns Dart, what advantage does standardization bring? The answer to what Google thinks it brings is indicated in the Chromium blog: 'The new standardization process is an important step towards a future where Dart runs natively in web browsers.' and this seems reasonable. A standard is something that would be required before other browser makers decided to fall in line and support native Dart. It is probably a necessary but far from sufficient condition, however, with Microsoft, Apple and Mozilla having other interests to further. Last but not least, having the backing of a standard might just encourage possible users to believe that the language won't sink if Google gets distracted with other projects and decides that Dart is dispensable. However, a strong open source development community capable of supporting Dart without Google's input would be a better reassurance. If you want to help, Google would like you to join the committee. After all, it still doesn't have a Vice Chair. So can we expect to see ECMA CoffeeScript or TypeScript in the near future? Probably not."
Nerval's Lobster writes "Computer scientists at Harvard University have come up with a way to convert algorithms that teach machines to learn into a form that would allow artificial intelligence to be programmed into complex chemical reactions. The ultimate result could be smart drugs programmed to react differently depending on which of several probable situations they might encounter – without the need to use nano-scale electronics to carry the instructions. 'This kind of chemical-based AI will be necessary for constructing therapies that sense and adapt to their environment,' according to Ryan P. Adams, assistant professor of computer science at Harvard's School of Engineering and Applied Sciences (SEAS), who co-wrote the paper explaining the technique. 'The hope is to eventually have drugs that can specialize themselves to your personal chemistry and can diagnose or treat a range of pathologies.' The techniques are part of a larger effort to program the behavior of molecules in manufacturing, decision-making and diagnostics, using both nano-scale electronics and the still-relatively-new study of bionanotechnology."